» Articles » PMID: 39066684

The Complex Interplay Between Encephalomyocarditis Virus and the Host Defence System

Overview
Journal Virulence
Specialty Microbiology
Date 2024 Jul 27
PMID 39066684
Authors
Affiliations
Soon will be listed here.
Abstract

A variety of animals can be infected by encephalomyocarditis virus (EMCV). EMCV is the established causative agent of myocarditis and encephalitis in some animals. EMCV causes high fatality in suckling and weaning piglets, making pigs the most susceptible domestic animal species. Importantly, EMCV has zoonotic potential to infect the human population. The ability of the pathogen to avoid and undermine the initial defence mechanism of the host contributes to its virulence and pathogenicity. A large body of literature highlights the intricate strategies employed by EMCV to escape the innate immune machinery to suit its "pathogenic needs." Here, we also provide examples on how EMCV interacts with certain host proteins to dampen the infection process. Hence, this concise review aims to summarize these findings in a compendium of decades of research on this exciting yet underappreciated topic.

References
1.
Taha E, Ono K, Eguchi T . Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion. Int J Mol Sci. 2019; 20(18). PMC: 6770223. DOI: 10.3390/ijms20184588. View

2.
Xu S, Xie J, Zhang X, Chen L, Bi Y, Li X . DDX56 antagonizes IFN-β production to enhance EMCV replication by inhibiting IRF3 nuclear translocation. Vet Microbiol. 2021; 264:109304. DOI: 10.1016/j.vetmic.2021.109304. View

3.
Schwarz E, Badorff C, Hiura T, Wessely R, Badorff A, Verma I . NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J Virol. 1998; 72(7):5654-60. PMC: 110231. DOI: 10.1128/JVI.72.7.5654-5660.1998. View

4.
Akira S, Uematsu S, Takeuchi O . Pathogen recognition and innate immunity. Cell. 2006; 124(4):783-801. DOI: 10.1016/j.cell.2006.02.015. View

5.
Narayan K, Waggoner L, Pham S, Hendricks G, Waggoner S, Conlon J . TRIM13 is a negative regulator of MDA5-mediated type I interferon production. J Virol. 2014; 88(18):10748-57. PMC: 4178852. DOI: 10.1128/JVI.02593-13. View